38
Participants
Start Date
January 31, 2013
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
Acthar
Acthar is given by subcutaneous (SC) injection (shot under the skin), at a dose of 40 units daily or 80 units every other day
Placebo
Placebo contains the same inactive ingredients as Acthar, and is given by SC injection
Steroid Drug
The patient's steroid regimen 7.5 to 30 mg/day of prednisone or equivalent, chronic/stable within the 4 weeks prior to screening.
Mallinckrodt Investigational Site, New York
Mallinckrodt Investigational Site, Great Neck
Mallinckrodt Investigational Site, Brooklyn
Mallinckrodt Investigational Site, Hershey
Mallinckrodt Investigational Site, Wyomissing
Mallinckrodt Investigational Site, Charlotte
Mallinckrodt Investigational Site, Orlando
Mallinckrodt Investigational Site, Miami Lakes
Mallinckrodt Investigational Site, Brandon
Mallinckrodt Investigational Site, Tampa
Mallinckrodt Investigational Site, Clearwater
Mallinckrodt Investigational Site, Granger
Mallinckrodt Investigational Site, Lansing
Mallinckrodt Investigational Site, Lansing
Mallinckrodt Investigational Site, Baton Rouge
Mallinckrodt Investigational Site, Jonesboro
Mallinckrodt Investigational Site, Houston
Mallinckrodt Investigational Site, Houston
Mallinckrodt Investigational Site, La Palma
Mallinckrodt Investigational Site, Long Beach
Mallinckrodt Investigational Site, Upland
Mallinckrodt Investigational Site, La Jolla
Lead Sponsor
Mallinckrodt
INDUSTRY